September 29, 2026 — Earth Science Tech is leveraging AI and other technology, along with the expertise of a focused IT department, to drive sustainable growth and ensure long-term value The company uses technology to drive down costs, improve operational efficiencies, and expand profit margins within its pharmacy and telemedicine platforms ETST also utilizes technology in marketing to increase patient and customer retention and drive brand loyalty During the recent Annual Meeting of Shareholders, CTO Chris Rose explained the company’s tech stack and developments that have enabled it to offer its in-house tools to other clinics as a white-label service Earth Science Tech (OTCQB: ETST) is a strategic holding company that brings together innovative businesses across the healthcare, pharmacy, technology and telemedicine, real estate, and consumer products spaces. The company employs a dedicated IT infrastructure department, led by Chief Technology Officer Chris Rose, that has enabled it to leverage new technology to cut costs, improve operational efficiencies, and expand profit margins across its pharmacy and telemedicine platforms.
September 29, 2026 — Approximately 86,000 vertebral fragility fractures occur annually in the UK, with most remaining undiagnosed. Nanox.
September 29, 2026 — Nutriband (NASDAQ: NTRB) announced that CEO Gareth Sheridan is featured in a new documentary by independent journalist and filmmaker Nick Shirley examining the opioid crisis in the United States. Sheridan discusses pharmaceutical innovation and technologies including Nutriband AVERSA (TM) abuse-deterrent platform, which is designed to reduce the risk of abuse, misuse, diversion and accidental exposure associated with high-risk medications while preserving access for patients with legitimate medical needs.
September 29, 2026 — NanoViricides, Inc. (NYSE American: NNVC) reported results for its fiscal year ended June 30, 2026, highlighting regulatory and clinical progress for broad-spectrum antiviral candidate NV-387.
September 29, 2026 — In July 2026, electricity demand in Texas shot past the existing record of 85. 5 gigawatts previously set and reached 91.
September 29, 2026 — Europe’s effort to shift away from fossil fuels is facing a problem that would once have seemed unlikely: electricity is sometimes becoming so plentiful that producers have to pay to sell it. During the first three months of 2026, electricity traded below zero for 1,223 hours across European Union day-ahead markets, according to the International Energy Agency.
September 29, 2026 — U. S.
September 29, 2026 — Chainalysis’ seventh annual Geography of Crypto report describes a crypto market that behaved very differently from previous downturns during the year ending June 2026. Bitcoin reached a record price before suffering its deepest dollar decline, dropping $67,000 between its high and subsequent low.
September 29, 2026 — American Fusion (OTC: AMFN) announced that Chief Technology Officer Dr. John E.
September 29, 2026 — TruGolf’s pending acquisition of Polymath is intended to combine an established Nasdaq-listed technology company with institutional-grade infrastructure for tokenized real-world assets. Polymath reported more than $132 million in tokenized assets issued, more than 65 active issuers, and over 50 ecosystem partners as of December 31, 2025.
September 29, 2026 — Xeriant (OTCQB: XERI) provided an update on ongoing production of NexBoard (TM) at its contract manufacturer, reporting that the company achieved nearly a 25% reduction in panel weight while maintaining the same dimensions. Xeriant said the manufacturing process is being used to establish material compatibility, equipment capabilities, cycle times and product consistency as it prepares for future production scaling.
September 29, 2026 — Lantern Pharma (NASDAQ: LTRN) announced a definitive agreement for the purchase and sale of 3,669,725 shares of common stock, or pre-funded warrants in lieu thereof, at $1. 09 per share in a registered direct offering expected to generate approximately $4 million in gross proceeds.
September 29, 2026 — Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that its wholly owned subsidiary, MindWave Innovations Inc.
September 29, 2026 — This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) reported that intermediate casing at its Lawson 5 well has been completed at approximately 1,100 meters measured depth, with drilling proceeding toward the Prairie Evaporite, interpreted as a key trap and seal for Natural Hydrogen accumulation.
September 29, 2026 — Greenland Mines (NASDAQ: GRML) (FSE: HK6) announced that it raised over $17 million through a registered direct offering of common stock at $13 per share, bringing its total capital raised over the past week to more than $59 million. The company said the financing strengthens its balance sheet and provides capital for planned exploration and development programs and its 2027 milestones across its Greenland portfolio.
September 29, 2026 — Uranium Energy (NYSE American: UEC) announced results for its fiscal year ended July 31, 2026, highlighting its expansion from one producing uranium mine in Wyoming to two mines in two states, the start of production at Burke Hollow in South Texas and continued development of a third mine at Ludeman in Wyoming. The company reported fourth-quarter production of 65,392 pounds of uranium at Christensen Ranch at a total cash cost of $28.
September 29, 2026 — TruGolf (NASDAQ: TRUG) announced that Chairman and Interim CEO Brenner Adams and Polymath Research Interim CEO and CFO Natalie Hirsch will present at The ThinkEquity Conference on Oct. 15, 2026, at the Mandarin Oriental in New York.
September 29, 2026 — Date: October 5-7, 2026 Venue: New York City Stocktwits brings the Stocktoberfest gathering to New York City from October 5–7, 2026. This multi-day experience brings traders, investors, public company executives, financial professionals, and content creators together in a shared, interactive forum.
September 28, 2026 — Orthopedic practice is moving away from a model that manages knee pain until the joint fails, to early structural intervention – a shift that raises the bar for what a cartilage repair product has to deliver. Regentis’ GelrinC is an acellular hydrogel implant designed to erode in a controlled, synchronized manner as surrounding cells regenerate hyaline-like cartilage, with Phase II data showing approximately 100% greater KOOS improvement than microfracture at two years.
September 28, 2026 — Orthopedic practice is moving away from a model that manages knee pain until the joint fails, to early structural intervention – a shift that raises the bar for what a cartilage repair product has to deliver. Regentis’ GelrinC is an acellular hydrogel implant designed to erode in a controlled, synchronized manner as surrounding cells regenerate hyaline-like cartilage, with Phase II data showing approximately 100% greater KOOS improvement than microfracture at two years.